CLINICAL_TRIALS
trial_result
· 2012-10-10
Clinical Trial Update: MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005) [Phase 1]
Summary
Phase 1 single-dose study of MK-1006 in Japanese patients with Type 2 Diabetes Mellitus, completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 1 | Status: COMPLETED | Results posted: 2012-10-10